Patients with metastatic non-small cell lung cancer will always
progress after chemotherapy, so most patients go on to be treated with immunotherapy, a type of therapy that uses the body's immune system to fight cancer.
Not exact matches
They found that it took longer for the disease to
progress in patients whose tumour DNA count in the blood fell by more than a half
after one cycle of
chemotherapy, compared with patients whose DNA count did not drop.
Progress in prevention and early detection, and the use of
chemotherapy after surgery (adjuvant
chemotherapy), have achieved significantly increase survival in this disease in the last ten years, but much remains to be done.
[iv] Nivolumab versus
chemotherapy in patients with advanced melanoma who
progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open - label, phase 3 trial.
Participants are being asked to take part in this study because they have advanced or metastatic non-small cell lung cancer that has recurred or
progressed after previous
chemotherapy (s) including a platinum - based treatment.
Of the 29 patients, 24 had
progressed after at least one round of systemic
chemotherapy.
Among those who tolerated the diet, two patients died early, one stopped
after 2 weeks due to personal reasons, one felt unable to stick to the diet
after 4 weeks, one stopped
after 6 and two stopped
after 7 and 8 weeks due to
progress of the disease, one had to discontinue
after 6 weeks to resume
chemotherapy and five completed the 3 month intervention period.
After a year of treatment with
chemotherapy by his referring veterinarian, Barkley's clinical signs were
progressing and he was brought to the UC Davis Veterinary Medical Teaching Hospital for a novel treatment offered by Dr. Michele Steffey, a leading cancer surgeon in the hospital's Soft Tissue Surgery Service.